RK

Active Director Director DIN 10325669
DIN 10325669 First appointment Sep 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value •••• Premium profile

About Rifa Khan

Data last updated:

Rifa Khan is a Director at Viqson Lifesciences Private Limited (since 2023). The company operates in Trading. Viqson Lifesciences Private Limited reported revenue of ₹18.2 Lakh (FY 2025).

DIN 10325669
Primary Designation Director
Industry Trading
First Appointment 20 Sep 2023
Oldest Company Age 5 yrs
Largest company Viqson Lifesciences Private Limited · ₹18.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Viqson Lifesciences Private Limited U51909UP2021PTC154120
Director20 Sep 20232021₹18.2 Lakh (FY 2025)Active

Board colleagues of Rifa Khan

NameDINCompanyDesignation
Shamim Ahmad08283383Viqson Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Viqson Lifesciences Private Limited
Premium access

Shareholding and investment profile for Rifa Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rifa Khan

Rifa Khan currently holds 1 directorship: Viqson Lifesciences Private Limited (Director, since 20 Sep 2023, revenue ₹18.2 Lakh (FY 2025)).

Rifa Khan was first appointed on 20 Sep 2023 as Director at Viqson Lifesciences Private Limited.

The current boards of Rifa Khan's companies include Shamim Ahmad (Viqson Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available